USD 43.12
(-0.65%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 45.43 Billion ZAR | 16.57% |
2023 | 41.62 Billion ZAR | 5.14% |
2022 | 39.58 Billion ZAR | 6.02% |
2021 | 37.33 Billion ZAR | 8.66% |
2020 | 34.36 Billion ZAR | 9.61% |
2019 | 31.35 Billion ZAR | 7.22% |
2018 | 29.23 Billion ZAR | 9.07% |
2017 | 26.8 Billion ZAR | 10.91% |
2016 | 24.17 Billion ZAR | 9.52% |
2015 | 22.07 Billion ZAR | 15.25% |
2014 | 19.14 Billion ZAR | 9.16% |
2013 | 17.54 Billion ZAR | 13.64% |
2012 | 15.43 Billion ZAR | 9.46% |
2011 | 14.1 Billion ZAR | 6.23% |
2010 | 13.27 Billion ZAR | 9.04% |
2009 | 12.17 Billion ZAR | 7.93% |
2008 | 11.28 Billion ZAR | 12.23% |
2007 | 10.05 Billion ZAR | 0.51% |
2006 | 10 Billion ZAR | 14.76% |
2005 | 8.71 Billion ZAR | 17.85% |
2004 | 7.39 Billion ZAR | 0.36% |
2003 | 7.36 Billion ZAR | 34.26% |
2002 | 5.48 Billion ZAR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q4 | 1.36 Billion USD | 0.0% |
2024 Q2 | 1.23 Billion USD | 0.0% |
2023 FY | 41.62 Billion ZAR | 5.14% |
2023 Q4 | 1.24 Billion USD | 0.0% |
2023 Q2 | 1.21 Billion USD | 0.0% |
2022 FY | 39.58 Billion ZAR | 6.02% |
2022 Q4 | 1.36 Billion USD | 0.0% |
2022 Q2 | 1.36 Billion USD | 0.0% |
2021 Q4 | 1.43 Billion USD | 0.0% |
2021 Q2 | 1.23 Billion USD | 0.0% |
2021 FY | 37.33 Billion ZAR | 8.66% |
2020 Q4 | 1.07 Billion USD | 0.0% |
2020 Q2 | 1.21 Billion USD | 0.0% |
2020 FY | 34.36 Billion ZAR | 9.61% |
2019 FY | 31.35 Billion ZAR | 7.22% |
2019 Q4 | 1.18 Billion USD | 0.0% |
2018 FY | 29.23 Billion ZAR | 9.07% |
2017 FY | 26.8 Billion ZAR | 10.91% |
2016 FY | 24.17 Billion ZAR | 9.52% |
2015 FY | 22.07 Billion ZAR | 15.25% |
2014 FY | 19.14 Billion ZAR | 9.16% |
2013 FY | 17.54 Billion ZAR | 13.64% |
2012 FY | 15.43 Billion ZAR | 9.46% |
2011 FY | 14.1 Billion ZAR | 6.23% |
2010 FY | 13.27 Billion ZAR | 9.04% |
2009 FY | 12.17 Billion ZAR | 7.93% |
2008 FY | 11.28 Billion ZAR | 12.23% |
2007 FY | 10.05 Billion ZAR | 0.51% |
2006 FY | 10 Billion ZAR | 14.76% |
2005 FY | 8.71 Billion ZAR | 17.85% |
2004 FY | 7.39 Billion ZAR | 0.36% |
2003 FY | 7.36 Billion ZAR | 34.26% |
2002 FY | 5.48 Billion ZAR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alternative Energy Partners, Inc. | - USD | -Infinity% |
Allstar Health Brands, Inc. | - USD | -Infinity% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -23172.865% |
Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -101980912.232% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | - USD | -Infinity% |
HealthWarehouse.com, Inc. | 20.28 Million USD | -223914.63% |
LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -34502.282% |
MedGen, Inc. | 1.05 USD | -4327394285614.286% |
Omni Health, Inc. | 4.69 Million USD | -967627.673% |
Oxford Investments Holdings Inc. | 61.16 Thousand USD | -74284465.207% |
Pineapple, Inc. | 381.89 Thousand USD | -11897996.31% |
ScripsAmerica, Inc. | 30.85 Million USD | -147163.479% |